Compare V & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | V | ABT |
|---|---|---|
| Founded | 1958 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 613.8B | 152.9B |
| IPO Year | 2007 | 2006 |
| Metric | V | ABT |
|---|---|---|
| Price | $332.29 | $90.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 20 |
| Target Price | ★ $394.18 | $130.90 |
| AVG Volume (30 Days) | 6.8M | ★ 8.9M |
| Earning Date | 04-28-2026 | 04-16-2026 |
| Dividend Yield | 0.80% | ★ 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | $21,846,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $13.85 | $10.75 |
| Revenue Next Year | $10.36 | $8.10 |
| P/E Ratio | ★ $30.09 | $145.40 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $293.89 | $81.97 |
| 52 Week High | $359.66 | $137.49 |
| Indicator | V | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 59.07 | 53.99 |
| Support Level | $320.32 | $84.96 |
| Resistance Level | $339.01 | $92.73 |
| Average True Range (ATR) | 7.03 | 1.83 |
| MACD | 0.27 | 0.47 |
| Stochastic Oscillator | 97.24 | 69.96 |
Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.